Rosen Law Firm Urges Medpace Stockholders to Contact Firm

Lawsuit alleges Medpace misled investors about financial performance.

Apr. 7, 2026 at 9:31pm

Got story updates? Submit your updates here. ›

A minimalist studio still life featuring a stack of financial documents, a pen, and a calculator arranged on a clean, monochromatic background, conceptually representing the investigation into Medpace's corporate finances.An investigation into Medpace's financial practices raises concerns about transparency and accountability in the contract research industry.NYC Today

The Rosen Law Firm, a global investor rights law firm, announced that it is investigating potential securities claims on behalf of shareholders of Medpace Holdings, Inc. (NASDAQ: MEDP) resulting from allegations that Medpace may have issued materially misleading business information to the investing public.

Why it matters

Medpace is a major contract research organization that provides clinical development services to the pharmaceutical, biotechnology, and medical device industries. Allegations of financial misconduct could significantly impact the company's reputation and operations.

The details

The Rosen Law Firm is investigating whether Medpace and its officers and/or directors have engaged in securities fraud or other unlawful business practices. Specifically, the firm is looking into claims that Medpace may have misled investors about its financial performance and business prospects.

  • The investigation was announced on April 7, 2026.

The players

Rosen Law Firm

A global investor rights law firm that specializes in representing shareholders in securities fraud class actions and shareholder derivative litigation.

Medpace Holdings, Inc.

A contract research organization that provides clinical development services to the pharmaceutical, biotechnology, and medical device industries.

Got photos? Submit your photos here. ›

What they’re saying

“We urge Medpace stockholders to contact us to discuss the potential case and their rights as shareholders.”

— Laurence Rosen, Managing Partner, Rosen Law Firm

What’s next

The Rosen Law Firm is encouraging Medpace shareholders to contact the firm to discuss the potential case and their rights as shareholders.

The takeaway

This investigation highlights the importance of transparency and accountability for publicly traded companies, as allegations of financial misconduct can significantly impact shareholder value and public trust.